Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117428 · ClinicalTrials.gov registry record · Phase 1
Sym004 in Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Symphogen A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 111
- Enrollment target
NCT01117428 is a Phase 1 study that has completed, run by Symphogen A/S. The registered enrollment target is 111 participants.
The verdict
NCT01117428, a Phase 1 study, has completed, sponsored by Symphogen A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 111 participants
- Enrollment target
Study Summary
This trial is designed as a multi-centre, open label, dose-escalation, phase I trial and consists of five parts.
Interventions
- DRUG Sym004
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2010-03 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01117428
The ClinicalTrials.gov registry entry for NCT01117428 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Symphogen A/S, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sym004 is the first listed.
NCT01117428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01117428 about?
NCT01117428 is a clinical study titled "Sym004 in Patients With Advanced Solid Tumors". This trial is designed as a multi-centre, open label, dose-escalation, phase I trial and consists of five parts.
What is the current status of trial NCT01117428?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 111 participants. The study started on 2010-03. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01117428?
The interventions under investigation include: Sym004 (DRUG).
Who is sponsoring clinical trial NCT01117428?
This trial is sponsored by Symphogen A/S, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.